| Name | Title | Contact Details |
|---|
Xodus Medical is a New Kensington, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Motus GI Holdings, Inc. (NASDAQ: MOTS) is a medical technology company based in the U.S., with subsidiaries in the U.S. and Israel, dedicated to improving endoscopy outcomes, lowering costs and enhancing patient experiences. The Company is focused on the development and commercialization of the Pure-Vu® System, designed to improve the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon.
At Mach7, our purpose is simple: to deliver to healthcare professionals the tools they need to help their patients achieve better health outcomes. Every day, medical practitioners face the challenge of bringing together an immense amount of patient data from multiple disparate sources while also finding a way to make sense of it. They must contend with issues like non-consolidated image storage, labor-intensive and inefficient workflows, and multiple viewers for different specialties and image types. With these obstacles in mind, Mach7 has built innovative solutions from the ground up that can integrate multiple systems, enable clinical collaboration, deliver vendor neutral archiving, provide enterprise-wide universal viewing, modernize legacy PACS, and more. Mach7 is focused on removing the technology limitations that inhibit the free flow of patient information and access to the complete patient medical record. We differ from many other companies in the industry by building an integrated imaging ecosystem where all technologies work together in harmony. Because we are built as an integration platform first, we give you the freedom to use the technologies that are important to your physicians and patients, even if they are from another vendor. This also means we offer the independence and flexibility to deploy these as individual components or a comprehensive end-to-end enterprise imaging platform. Through this, we help organizations increase their efficiency, achieve profound operational cost savings, leverage their existing IT investments, improve the experience for patients and medical professionals, and, ultimately, support healthier outcomes.
Contego Medical, founded in 2005, has developed a family of novel emboli protection devices. The main feature of each device is that the treatment portion (i.e., balloon or stent) is on the same catheter as the embolic protection device, thus coupling the two together. This device can act as an angioplasty balloon with an integrated emboli protection device. If a stent is mounted on the balloon, it can serve as a stent with an integrated emboli protection device. We know that embolization occurs with all angioplasty and stenting procedures. It is usually hard to predict which ones will result in clinical sequalae. Despite knowing that embolization is ubiquitous, embolic protection devices are not used in all procedures as they add complexity, time, and cost. Dedicated devices do not exist for renal intervention, although the majority of physicians say they would use one if it existed. Contego Medical’s family of embolic protection devices represent a paradigm shift in the treatment of cardiovascular disease.
Potrero Medical is a predictive health company that is developing the next generation of smart sensors and artificial intelligence.